Actions for Sun Pharmaceutical Industries Limited : a star player for portfolio managers?

Email RIS file
Bookmark
Report an Issue

Sun Pharmaceutical Industries Limited : a star player for portfolio managers? / Amrit Mohapatra, Gaurav K. Gupta, Ashish Chaurasia

Author
Mohapatra, Amrit
Published
London : SAGE Publications: SAGE Business Cases Originals, 2022.
Physical Description
1 online resource : illustrations
Additional Creators
Gupta, Gaurav K. and Chaurasia, Ashish
Access Online

Availability

I Want It
I Want It

Finding items...

Series
Summary
Sun Pharmaceutical Industries Limited (SPIL) is India's largest pharmaceutical company in terms of market share and is an industry driver for the pharma sector. Starting in 2015, the company's growth prospects had been on decline, and this trend continued until the pre-COVID outbreak period. However, the pandemic offered the opportunity for the recovery and growth of the company. This case allows students to assess the company by employing the economy, industry, and company (EIC) framework. This method is a top-down approach that aims to understand whether the firm's stocks are safe to invest in based on intrinsic valuation using the discounted cash flow to the firm and dividend discounting model concept.
Subject(s)
ISBN
9781529795127 (ebook)
Bibliography Note
Includes bibliographical references and index.
View MARC record | catkey: 47382780